Pre-wired ability in ‘resting’ T cells to remember past viral foes discovered, a promising breakthrough for targeted cancer therapies. A team of immunologists at the University of Massachusetts ...
CD8 + cytotoxic T lymphocytes (CTLs) serve as central effectors in cancer immunotherapy by directly eliminating tumor cells. However, current clinical therapies face significant limitations. These ...
Hosted on MSN
What determines the fate of a T cell? Research highlights cellular 'housekeeping' mechanism
When killer T cells of our immune system divide, they normally undergo asymmetric cell division (ACD): Each daughter cell inherits different cellular components, which drive the cells toward divergent ...
Researchers released a consensus statement with recommendations to update T cell nomenclature and improve communication ...
Complete clearance lasts for a very long time due to knockout of resident memory T cells within the skin,’ said the study’s ...
Researchers from the Keck School of Medicine of USC have developed a new type of chimeric antigen receptor (CAR) T cell that elicits a more controlled immune response to cancer in mice—effectively ...
IL-15 enhances the growth and survival of GPC3 CAR T cells, improving their ability to target and fight solid tumors Study: Interleukin-15-armoured GPC3 CAR T cells for patients with solid cancers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback